Altitude Life Science Ventures

Portfolio Co Investors 2026 for Altitude Life Science Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research.

Altitude Life Science Ventures accounts for 12 tracked companies with verified cap-table data, 12 of which disclose round sizes totalling $3.2B. The median disclosed raise is $240M, and the largest is Sana Biotechnology at $700M, ahead of Neumora Therapeutics ($500M) and Vividion Therapeutics ($362M).

The names that recur most often on these co-invested cap tables are Altitude Life Science Ventures (12 companies), ARCH Venture Partners (6 companies), Alexandria Venture Investments (4 companies), Flagship Pioneering (3 companies), F-Prime Capital (2 companies), Baillie Gifford (2 companies). By latest disclosed round, the market skews Series A (4), Series B (2), Series D (2), Series C (2).

Best funded Altitude Life Science Ventures companies

  1. Sana Biotechnology — $700M (latest: IPO)
  2. Neumora Therapeutics — $500M (latest: Series A)
  3. Vividion Therapeutics — $362M (latest: Series B)
  4. Indigo AG — $300M (latest: Series D)
  5. Nuvation Bio — $275M (latest: Series A)
  6. Encoded Therapeutics — $240M (latest: Series D)
  7. Escient Pharmaceuticals — $238M (latest: Series C)
  8. Lila Sciences — $200M (latest: Seed)
  9. Omniome — $160M (latest: Series C)
  10. Ring Therapeutics — $117M (latest: Series B)
  11. Mozart Therapeutics — $80M (latest: Series A)
  12. Cero Therapeutics — $40M (latest: Series A)

Altitude Life Science Ventures — related firms and companies (56)

Altitude Life Science Ventures alternatives · All research reports